Clinical Trial Update: Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

This completed Phase 3 trial evaluated the efficacy and safety of combining pioglitazone with metformin in subjects with Type 2 diabetes mellitus and metabolic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)
• metformin (metformin)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED